Fundraising Fox
NuShores Biosciences
Little Rock, US · Founded 2014 · Arkansas LLC
Find your way into NuShores Biosciences
Each arrow is one introduction. Sign up to fill in the first one.
Ask Ilka Gomez to introduce you to David E. Anderson
You →Ilka · together at The Ohio State University →David
Sign up to find every way you can get introduced to NuShores Biosciences
- Your email: who you already know at NuShores Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NuShores Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
Founders & leadership
NuShores Biosciences was founded in 2014 by Alexandru S. Biris, Andrew G. Kumpuris, and David E. Anderson.
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 2 rounds · 2017–2020
▶$1.5MraisedMar 2022 · 4 investors · BiotechnologyRule 506(b)
- Sharon BallardExecutive Officer, Director
- Alex BirisExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- First sale
- Jul 2020
- Incorporated
- Limited Liability Company, Arkansas
- Federal exemptions
- 06b
▶$1.1MraisedJan 2019 · 8 investors · BiotechnologyRule 506(b)
- Sharon BallardExecutive Officer, Director
- Alex S. BirisExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, Arkansas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as NuShores Biosciences.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NuShores Biosciences do?
- NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
- Who founded NuShores Biosciences?
- NuShores Biosciences was founded by Alexandru S. Biris, Andrew G. Kumpuris, David E. Anderson in 2014.
- How much funding has NuShores Biosciences raised?
- NuShores Biosciences has disclosed $2.6M raised across 2 rounds.
- Where is NuShores Biosciences headquartered?
- NuShores Biosciences is headquartered in Little Rock, US.